Pregabalin Shortage Update: What Patients Need to Know in 2026

If you or a family member depends on pregabalin (Lyrica) for nerve pain, fibromyalgia, or seizure control, recent news about drug shortages may have you worried. Here's a clear, up-to-date look at the status of pregabalin availability in 2026 — and what to do if your pharmacy doesn't have it.

Pregabalin Shortage Status in 2026: The Direct Answer

As of early 2026, pregabalin is NOT on the FDA's active drug shortage list. This is good news. The FDA only lists drugs with confirmed, significant supply disruptions that affect patient care nationwide. Pregabalin does not meet that threshold.

Generic pregabalin became available in the United States in 2019 when Lyrica's patent exclusivity expired. Since then, multiple pharmaceutical manufacturers have been producing the drug, creating a more robust supply chain than the brand-name-only era. This competition among generics has also brought prices down dramatically.

Why Do Patients Still Report Difficulty Finding Pregabalin?

Even without a national shortage, patients across the US regularly report difficulty filling pregabalin prescriptions. This disconnect between national supply and local availability is real — and important to understand:

• Pharmacy-level stock-outs. Individual pharmacies — especially smaller ones — can temporarily run out of specific strengths. This doesn't indicate a manufacturing problem; it's often just a mismatch between ordering frequency and local demand.
• Controlled substance complexity. Pregabalin is a DEA Schedule V controlled substance. Pharmacies face additional regulatory requirements when ordering and dispensing controlled substances, which can slow restocking timelines compared to non-scheduled drugs.
• High demand across multiple specialties. Pregabalin is prescribed by neurologists, pain specialists, rheumatologists, psychiatrists, and primary care physicians. Very high demand means pharmacies cycle through inventory quickly.
• Multiple strengths in the same drug. Pregabalin comes in 8 capsule strengths plus an oral solution and extended-release tablets. A pharmacy may have some strengths in stock but not others.

A Brief History of Pregabalin Availability

Pregabalin (Lyrica) was first approved by the FDA in December 2004 and came to market in 2005. For over a decade, Pfizer (and later Viatris) held exclusive rights, keeping prices extremely high — often over $300–$400 per month. When generic manufacturers entered the market in 2019, supply increased substantially and prices dropped.

Pregabalin has not appeared on the FDA shortage list as a drug requiring emergency action. In this way, it differs from medications like Adderall (amphetamine salts) or semaglutide, which experienced genuine, widespread manufacturing shortages affecting patient care nationwide.

What to Do If You Can't Fill Your Pregabalin Prescription

If your pharmacy is out of stock, these steps — in this order — give you the best chance of getting your medication quickly:

1. Use medfinder: medfinder contacts pharmacies near you to check which ones can fill your prescription — saving you from hours of phone calls.
2. Try a different pharmacy: Large chains (Walgreens, CVS, Walmart) and grocery store pharmacies often carry more inventory. Availability varies significantly between locations even in the same city.
3. Ask for a partial fill: Many pharmacies can dispense a partial supply while waiting for a full restock.
4. Contact your prescriber: Your doctor may be able to prescribe a different strength as a temporary workaround, or recommend an alternative if stock can't be found quickly.
5. Consider mail-order pharmacy: Mail-order pharmacies typically carry larger inventories. Many insurance plans offer this for 90-day supplies.

Do NOT Stop Pregabalin Suddenly

This point cannot be overstated: abrupt discontinuation of pregabalin is dangerous. Withdrawal symptoms can include insomnia, headache, nausea, anxiety, diarrhea, and in severe cases, seizures — even in people who have not used it for seizure control. The FDA-approved prescribing information recommends tapering over a minimum of one week. If you're running low, contact your prescriber before you run out completely.

Cost and Insurance Issues That Feel Like a Shortage

Sometimes what patients describe as a "shortage" is actually a coverage or cost problem: a pharmacy may have the medication but a patient's insurance won't cover it, or the copay has become unaffordable. Here's the current pricing landscape:

• Generic pregabalin without insurance: Average retail price around $330/month, but discount coupons (GoodRx, SingleCare) can bring this as low as $12–$14 for a 30-day supply at most major pharmacies.
• With commercial insurance: Generic pregabalin is typically covered as a Tier 2 drug, with copays of $0–$30 per month for most plans.
• Brand Lyrica: Extremely expensive without insurance — over $1,500/month. Viatris offers a manufacturer savings card for commercially insured patients that can reduce the cost to as low as $4 per prescription.

The Bottom Line for Patients in 2026

Pregabalin is not in a national shortage in 2026. However, pharmacy-level stock-outs do occur. If your local pharmacy doesn't have your dose, try other locations, ask for a partial fill, or use medfinder to locate it nearby. If you genuinely cannot find it, talk to your doctor about temporary alternatives — but never stop pregabalin abruptly.